APO Research
Talk to an analyst

APO RESEARCH · REPORT

Carmustine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Carmustine Industry Growth and Trends Forecast to 2032

23 December 2025109 pages

Choose your research edition.

Industry ResearchCarmustine Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Carmustine Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Carmustine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Carmustine Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Carmustine Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Carmustine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Carmustine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Carmustine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Carmustine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Carmustine include Eisai, Tianjin Kingyork, Zydus Pharmaceuticals, Bristol-Myers Squibb, STI Pharma, Sanli Ilac, Pharmaplan, Obvius Pharmaceuticals and Navinta, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Carmustine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Carmustine market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Carmustine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Carmustine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Carmustine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Carmustine Market by Company

Eisai

Tianjin Kingyork

Zydus Pharmaceuticals

Bristol-Myers Squibb

STI Pharma

Sanli Ilac

Pharmaplan

Obvius Pharmaceuticals

Navinta

MGI Pharma

Marcan Pharmaceuticals

Emcure Pharms

Arbor Pharms

Amneal Pharms

Carmustine Segment by Type

100mg Injection

125mg Injection

Carmustine Segment by Application

Medulloblastoma and Astrocytoma

Multiple Myeloma

Glioblastoma Multiforme

Lymphoma

Glioma

Others

Carmustine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Carmustine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Carmustine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Carmustine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Carmustine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Carmustine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 100mg Injection Table 2. Major Company of 125mg Injection Table 3. Global Carmustine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Carmustine Sales by Type (2021-2026) & (k units) Table 5. Global Carmustine Sales Market Share in Volume by Type (2021-2026) Table 6. Global Carmustine Sales by Type (2021-2026) & (US$ Million) Table 7. Global Carmustine Sales Market Share in Value by Type (2021-2026) Table 8. Global Carmustine Price by Type (2021-2026) & (US$/unit) Table 9. Global Carmustine Sales by Type (2027-2032) & (k units) Table 10. Global Carmustine Sales Market Share in Volume by Type (2027-2032) Table 11. Global Carmustine Sales by Type (2027-2032) & (US$ Million) Table 12. Global Carmustine Sales Market Share in Value by Type (2027-2032) Table 13. Global Carmustine Price by Type (2027-2032) & (US$/unit) Table 14. North America Carmustine Sales by Type (2021-2026) & (k units) Table 15. North America Carmustine Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Carmustine Sales by Type (2021-2026) & (k units) Table 17. Europe Carmustine Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Carmustine Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Carmustine Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Carmustine Sales by Type (2021-2026) & (k units) Table 21. Latin America Carmustine Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Carmustine Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Carmustine Sales by Type (2021-2026) & (US$ Million) Table 24. Carmustine Industry Trends Table 25. Carmustine Industry Drivers Table 26. Carmustine Industry Opportunities and Challenges Table 27. Carmustine Industry Restraints Table 28. Global Carmustine Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Carmustine Revenue Market Share by Company (2021-2026) Table 30. Global Carmustine Sales by Company (2021-2026) & (k units) Table 31. Global Carmustine Sales Share by Company (2021-2026) Table 32. Global Carmustine Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Carmustine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Carmustine Major Company Production Sites and Headquarters Table 35. Global Carmustine Company, Product Type & Application Table 36. Global Carmustine Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Carmustine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Carmustine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Carmustine Sales by Region (2021-2026) & (k units) Table 41. Global Carmustine Sales Market Share in Volume by Region (2021-2026) Table 42. Global Carmustine Sales by Region (2021-2026) & (US$ Million) Table 43. Global Carmustine Sales Market Share in Value by Region (2021-2026) Table 44. Global Carmustine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Carmustine Sales by Region (2027-2032) & (k units) Table 46. Global Carmustine Sales Market Share in Volume by Region (2027-2032) Table 47. Global Carmustine Sales by Region (2027-2032) & (US$ Million) Table 48. Global Carmustine Sales Market Share in Value by Region (2027-2032) Table 49. Global Carmustine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Carmustine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Carmustine Sales by Application (2021-2026) & (k units) Table 52. Global Carmustine Sales Market Share in Volume by Application (2021-2026) Table 53. Global Carmustine Sales by Application (2021-2026) & (US$ Million) Table 54. Global Carmustine Sales Market Share in Value by Application (2021-2026) Table 55. Global Carmustine Price by Application (2021-2026) & (US$/unit) Table 56. Global Carmustine Sales by Application (2027-2032) & (k units) Table 57. Global Carmustine Sales Market Share in Volume by Application (2027-2032) Table 58. Global Carmustine Sales by Application (2027-2032) & (US$ Million) Table 59. Global Carmustine Sales Market Share in Value by Application (2027-2032) Table 60. Global Carmustine Price by Application (2027-2032) & (US$/unit) Table 61. North America Carmustine Sales by Application (2021-2026) & (k units) Table 62. North America Carmustine Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Carmustine Sales by Application (2021-2026) & (k units) Table 64. Europe Carmustine Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Carmustine Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Carmustine Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Carmustine Sales by Application (2021-2026) & (k units) Table 68. Latin America Carmustine Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Carmustine Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Carmustine Sales by Application (2021-2026) & (US$ Million) Table 71. Eisai Company Information Table 72. Eisai Business Overview Table 73. Eisai Carmustine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Eisai Carmustine Product Portfolio Table 75. Eisai Recent Development Table 76. Tianjin Kingyork Company Information Table 77. Tianjin Kingyork Business Overview Table 78. Tianjin Kingyork Carmustine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Tianjin Kingyork Carmustine Product Portfolio Table 80. Tianjin Kingyork Recent Development Table 81. Zydus Pharmaceuticals Company Information Table 82. Zydus Pharmaceuticals Business Overview Table 83. Zydus Pharmaceuticals Carmustine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Zydus Pharmaceuticals Carmustine Product Portfolio Table 85. Zydus Pharmaceuticals Recent Development Table 86. Bristol-Myers Squibb Company Information Table 87. Bristol-Myers Squibb Business Overview Table 88. Bristol-Myers Squibb Carmustine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Bristol-Myers Squibb Carmustine Product Portfolio Table 90. Bristol-Myers Squibb Recent Development Table 91. STI Pharma Company Information Table 92. STI Pharma Business Overview Table 93. STI Pharma Carmustine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. STI Pharma Carmustine Product Portfolio Table 95. STI Pharma Recent Development Table 96. Sanli Ilac Company Information Table 97. Sanli Ilac Business Overview Table 98. Sanli Ilac Carmustine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Sanli Ilac Carmustine Product Portfolio Table 100. Sanli Ilac Recent Development Table 101. Pharmaplan Company Information Table 102. Pharmaplan Business Overview Table 103. Pharmaplan Carmustine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. Pharmaplan Carmustine Product Portfolio Table 105. Pharmaplan Recent Development Table 106. Obvius Pharmaceuticals Company Information Table 107. Obvius Pharmaceuticals Business Overview Table 108. Obvius Pharmaceuticals Carmustine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. Obvius Pharmaceuticals Carmustine Product Portfolio Table 110. Obvius Pharmaceuticals Recent Development Table 111. Navinta Company Information Table 112. Navinta Business Overview Table 113. Navinta Carmustine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 114. Navinta Carmustine Product Portfolio Table 115. Navinta Recent Development Table 116. MGI Pharma Company Information Table 117. MGI Pharma Business Overview Table 118. MGI Pharma Carmustine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 119. MGI Pharma Carmustine Product Portfolio Table 120. MGI Pharma Recent Development Table 121. Marcan Pharmaceuticals Company Information Table 122. Marcan Pharmaceuticals Business Overview Table 123. Marcan Pharmaceuticals Carmustine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 124. Marcan Pharmaceuticals Carmustine Product Portfolio Table 125. Marcan Pharmaceuticals Recent Development Table 126. Emcure Pharms Company Information Table 127. Emcure Pharms Business Overview Table 128. Emcure Pharms Carmustine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 129. Emcure Pharms Carmustine Product Portfolio Table 130. Emcure Pharms Recent Development Table 131. Arbor Pharms Company Information Table 132. Arbor Pharms Business Overview Table 133. Arbor Pharms Carmustine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 134. Arbor Pharms Carmustine Product Portfolio Table 135. Arbor Pharms Recent Development Table 136. Amneal Pharms Company Information Table 137. Amneal Pharms Business Overview Table 138. Amneal Pharms Carmustine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 139. Amneal Pharms Carmustine Product Portfolio Table 140. Amneal Pharms Recent Development Table 141. North America Carmustine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 142. North America Carmustine Sales by Country (2021-2026) & (k units) Table 143. North America Carmustine Sales Market Share by Country (2021-2026) Table 144. North America Carmustine Sales Forecast by Country (2027-2032) & (k units) Table 145. North America Carmustine Sales Market Share Forecast by Country (2027-2032) Table 146. North America Carmustine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. North America Carmustine Market Size by Country (2021-2026) & (US$ Million) Table 148. North America Carmustine Market Share by Country (2021-2026) Table 149. North America Carmustine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. North America Carmustine Market Share Forecast by Country (2027-2032) Table 151. Europe Carmustine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 152. Europe Carmustine Sales by Country (2021-2026) & (k units) Table 153. Europe Carmustine Sales Market Share by Country (2021-2026) Table 154. Europe Carmustine Sales Forecast by Country (2027-2032) & (k units) Table 155. Europe Carmustine Sales Market Share Forecast by Country (2027-2032) Table 156. Europe Carmustine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Europe Carmustine Market Size by Country (2021-2026) & (US$ Million) Table 158. Europe Carmustine Market Share by Country (2021-2026) Table 159. Europe Carmustine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Europe Carmustine Market Share Forecast by Country (2027-2032) Table 161. Asia-Pacific Carmustine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 162. Asia-Pacific Carmustine Sales by Country (2021-2026) & (k units) Table 163. Asia-Pacific Carmustine Sales Market Share by Country (2021-2026) Table 164. Asia-Pacific Carmustine Sales Forecast by Country (2027-2032) & (k units) Table 165. Asia-Pacific Carmustine Sales Market Share Forecast by Country (2027-2032) Table 166. Asia-Pacific Carmustine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Asia-Pacific Carmustine Market Size by Country (2021-2026) & (US$ Million) Table 168. Asia-Pacific Carmustine Market Share by Country (2021-2026) Table 169. Asia-Pacific Carmustine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Asia-Pacific Carmustine Market Share Forecast by Country (2027-2032) Table 171. Latin America Carmustine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 172. Latin America Carmustine Sales by Country (2021-2026) & (k units) Table 173. Latin America Carmustine Sales Market Share by Country (2021-2026) Table 174. Latin America Carmustine Sales Forecast by Country (2027-2032) & (k units) Table 175. Latin America Carmustine Sales Market Share Forecast by Country (2027-2032) Table 176. Latin America Carmustine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. Latin America Carmustine Market Size by Country (2021-2026) & (US$ Million) Table 178. Latin America Carmustine Market Share by Country (2021-2026) Table 179. Latin America Carmustine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. Latin America Carmustine Market Share Forecast by Country (2027-2032) Table 181. Middle East and Africa Carmustine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 182. Middle East and Africa Carmustine Sales by Country (2021-2026) & (k units) Table 183. Middle East and Africa Carmustine Sales Market Share by Country (2021-2026) Table 184. Middle East and Africa Carmustine Sales Forecast by Country (2027-2032) & (k units) Table 185. Middle East and Africa Carmustine Sales Market Share Forecast by Country (2027-2032) Table 186. Middle East and Africa Carmustine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 187. Middle East and Africa Carmustine Market Size by Country (2021-2026) & (US$ Million) Table 188. Middle East and Africa Carmustine Market Share by Country (2021-2026) Table 189. Middle East and Africa Carmustine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 190. Middle East and Africa Carmustine Market Share Forecast by Country (2027-2032) Table 191. Key Raw Materials Table 192. Raw Materials Key Suppliers Table 193. Carmustine Distributors List Table 194. Carmustine Customers List Table 195. Research Programs/Design for This Report Table 196. Authors List of This Report Table 197. Secondary Sources Table 198. Primary Sources List of Figures Figure 1. Carmustine Image Figure 2. Global Carmustine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Carmustine Market Size (2021-2032) & (US$ Million) Figure 4. Global Carmustine Sales (2021-2032) & (k units) Figure 5. 100mg Injection Image Figure 6. Global 100mg Injection Sales YoY Growth (2021-2032) & (k units) Figure 7. 125mg Injection Image Figure 8. Global 125mg Injection Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Carmustine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Carmustine Market Share by Type 2025 VS 2032 Figure 11. North America Carmustine Sales Market Share in Volume by Type in 2025 Figure 12. North America Carmustine Sales Market Share in Value by Type in 2025 Figure 13. Europe Carmustine Sales Market Share in Volume by Type in 2025 Figure 14. Europe Carmustine Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Carmustine Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Carmustine Sales Market Share in Value by Type in 2025 Figure 17. Latin America Carmustine Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Carmustine Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Carmustine Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Carmustine Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Carmustine Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Medulloblastoma and Astrocytoma Image Figure 24. Global Medulloblastoma and Astrocytoma Sales YoY Growth (2021-2032) & (k units) Figure 25. Multiple Myeloma Image Figure 26. Global Multiple Myeloma Sales YoY Growth (2021-2032) & (k units) Figure 27. Glioblastoma Multiforme Image Figure 28. Global Glioblastoma Multiforme Sales YoY Growth (2021-2032) & (k units) Figure 29. Lymphoma Image Figure 30. Global Lymphoma Sales YoY Growth (2021-2032) & (k units) Figure 31. Glioma Image Figure 32. Global Glioma Sales YoY Growth (2021-2032) & (k units) Figure 33. Others Image Figure 34. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 35. Global Carmustine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Carmustine Market Share by Application 2025 VS 2032 Figure 37. North America Carmustine Sales Market Share in Volume by Application in 2025 Figure 38. North America Carmustine Sales Market Share in Value by Application in 2025 Figure 39. Europe Carmustine Sales Market Share in Volume by Application in 2025 Figure 40. Europe Carmustine Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Carmustine Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Carmustine Sales Market Share in Value by Application in 2025 Figure 43. Latin America Carmustine Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Carmustine Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Carmustine Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Carmustine Sales Market Share in Value by Application in 2025 Figure 47. North America Carmustine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. North America Carmustine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Carmustine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Carmustine Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Carmustine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Europe Carmustine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Carmustine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Carmustine Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Carmustine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Asia-Pacific Carmustine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Carmustine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Carmustine Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Carmustine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 60. Latin America Carmustine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Carmustine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Carmustine Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Carmustine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 64. Middle East and Africa Carmustine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Carmustine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Carmustine Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Carmustine Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Carmustine Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • 100mg Injection
  • 125mg Injection
Applications
  • Medulloblastoma and Astrocytoma
  • Multiple Myeloma
  • Glioblastoma Multiforme
  • Lymphoma
  • Glioma
  • Others
Companies covered
  • Eisai
  • Tianjin Kingyork
  • Zydus Pharmaceuticals
  • Bristol-Myers Squibb
  • STI Pharma
  • Sanli Ilac
  • Pharmaplan
  • Obvius Pharmaceuticals
  • Navinta
  • MGI Pharma
  • Marcan Pharmaceuticals
  • Emcure Pharms
  • Arbor Pharms
  • Amneal Pharms

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Carmustine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Carmustine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Carmustine Market by Type
  6. 1.3.1 100mg Injection
  7. 1.3.2 125mg Injection
  8. 1.4 Global Carmustine Market Size by Type
  9. 1.4.1 Global Carmustine Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Carmustine Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Carmustine Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Carmustine Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Carmustine Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Carmustine Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Carmustine Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Carmustine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Carmustine Industry Trends
  2. 2.2 Carmustine Industry Drivers
  3. 2.3 Carmustine Industry Opportunities and Challenges
  4. 2.4 Carmustine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Carmustine Revenue (2021-2026)
  2. 3.2 Global Top Players by Carmustine Sales (2021-2026)
  3. 3.3 Global Top Players by Carmustine Price (2021-2026)
  4. 3.4 Global Carmustine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Carmustine Major Company Production Sites & Headquarters
  6. 3.6 Global Carmustine Company, Product Type & Application
  7. 3.7 Global Carmustine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Carmustine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Carmustine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Carmustine Tier 1, Tier 2, and Tier 3
4 Carmustine Regional Status and Outlook
  1. 4.1 Global Carmustine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Carmustine Historic Market Size by Region
  3. 4.2.1 Global Carmustine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Carmustine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Carmustine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Carmustine Forecasted Market Size by Region
  7. 4.3.1 Global Carmustine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Carmustine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Carmustine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Carmustine by Application
  1. 5.1 Carmustine Market by Application
  2. 5.1.1 Medulloblastoma and Astrocytoma
  3. 5.1.2 Multiple Myeloma
  4. 5.1.3 Glioblastoma Multiforme
  5. 5.1.4 Lymphoma
  6. 5.1.5 Glioma
  7. 5.1.6 Others
  8. 5.2 Global Carmustine Market Size by Application
  9. 5.2.1 Global Carmustine Market Size Overview by Application (2021-2032)
  10. 5.2.2 Global Carmustine Historic Market Size Review by Application (2021-2026)
  11. 5.2.3 Global Carmustine Forecasted Market Size by Application (2027-2032)
  12. 5.3 Key Regions Market Size by Application
  13. 5.3.1 North America Carmustine Sales Breakdown by Application (2021-2026)
  14. 5.3.2 Europe Carmustine Sales Breakdown by Application (2021-2026)
  15. 5.3.3 Asia-Pacific Carmustine Sales Breakdown by Application (2021-2026)
  16. 5.3.4 South America Carmustine Sales Breakdown by Application (2021-2026)
  17. 5.3.5 Middle East and Africa Carmustine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Eisai
  2. 6.1.1 Eisai Company Information
  3. 6.1.2 Eisai Business Overview
  4. 6.1.3 Eisai Carmustine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Eisai Carmustine Product Portfolio
  6. 6.1.5 Eisai Recent Developments
  7. 6.2 Tianjin Kingyork
  8. 6.2.1 Tianjin Kingyork Company Information
  9. 6.2.2 Tianjin Kingyork Business Overview
  10. 6.2.3 Tianjin Kingyork Carmustine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Tianjin Kingyork Carmustine Product Portfolio
  12. 6.2.5 Tianjin Kingyork Recent Developments
  13. 6.3 Zydus Pharmaceuticals
  14. 6.3.1 Zydus Pharmaceuticals Company Information
  15. 6.3.2 Zydus Pharmaceuticals Business Overview
  16. 6.3.3 Zydus Pharmaceuticals Carmustine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Zydus Pharmaceuticals Carmustine Product Portfolio
  18. 6.3.5 Zydus Pharmaceuticals Recent Developments
  19. 6.4 Bristol-Myers Squibb
  20. 6.4.1 Bristol-Myers Squibb Company Information
  21. 6.4.2 Bristol-Myers Squibb Business Overview
  22. 6.4.3 Bristol-Myers Squibb Carmustine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Bristol-Myers Squibb Carmustine Product Portfolio
  24. 6.4.5 Bristol-Myers Squibb Recent Developments
  25. 6.5 STI Pharma
  26. 6.5.1 STI Pharma Company Information
  27. 6.5.2 STI Pharma Business Overview
  28. 6.5.3 STI Pharma Carmustine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 STI Pharma Carmustine Product Portfolio
  30. 6.5.5 STI Pharma Recent Developments
  31. 6.6 Sanli Ilac
  32. 6.6.1 Sanli Ilac Company Information
  33. 6.6.2 Sanli Ilac Business Overview
  34. 6.6.3 Sanli Ilac Carmustine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Sanli Ilac Carmustine Product Portfolio
  36. 6.6.5 Sanli Ilac Recent Developments
  37. 6.7 Pharmaplan
  38. 6.7.1 Pharmaplan Company Information
  39. 6.7.2 Pharmaplan Business Overview
  40. 6.7.3 Pharmaplan Carmustine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Pharmaplan Carmustine Product Portfolio
  42. 6.7.5 Pharmaplan Recent Developments
  43. 6.8 Obvius Pharmaceuticals
  44. 6.8.1 Obvius Pharmaceuticals Company Information
  45. 6.8.2 Obvius Pharmaceuticals Business Overview
  46. 6.8.3 Obvius Pharmaceuticals Carmustine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Obvius Pharmaceuticals Carmustine Product Portfolio
  48. 6.8.5 Obvius Pharmaceuticals Recent Developments
  49. 6.9 Navinta
  50. 6.9.1 Navinta Company Information
  51. 6.9.2 Navinta Business Overview
  52. 6.9.3 Navinta Carmustine Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Navinta Carmustine Product Portfolio
  54. 6.9.5 Navinta Recent Developments
  55. 6.10 MGI Pharma
  56. 6.10.1 MGI Pharma Company Information
  57. 6.10.2 MGI Pharma Business Overview
  58. 6.10.3 MGI Pharma Carmustine Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 MGI Pharma Carmustine Product Portfolio
  60. 6.10.5 MGI Pharma Recent Developments
  61. 6.11 Marcan Pharmaceuticals
  62. 6.11.1 Marcan Pharmaceuticals Company Information
  63. 6.11.2 Marcan Pharmaceuticals Business Overview
  64. 6.11.3 Marcan Pharmaceuticals Carmustine Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Marcan Pharmaceuticals Carmustine Product Portfolio
  66. 6.11.5 Marcan Pharmaceuticals Recent Developments
  67. 6.12 Emcure Pharms
  68. 6.12.1 Emcure Pharms Company Information
  69. 6.12.2 Emcure Pharms Business Overview
  70. 6.12.3 Emcure Pharms Carmustine Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Emcure Pharms Carmustine Product Portfolio
  72. 6.12.5 Emcure Pharms Recent Developments
  73. 6.13 Arbor Pharms
  74. 6.13.1 Arbor Pharms Company Information
  75. 6.13.2 Arbor Pharms Business Overview
  76. 6.13.3 Arbor Pharms Carmustine Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Arbor Pharms Carmustine Product Portfolio
  78. 6.13.5 Arbor Pharms Recent Developments
  79. 6.14 Amneal Pharms
  80. 6.14.1 Amneal Pharms Company Information
  81. 6.14.2 Amneal Pharms Business Overview
  82. 6.14.3 Amneal Pharms Carmustine Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Amneal Pharms Carmustine Product Portfolio
  84. 6.14.5 Amneal Pharms Recent Developments
7 North America by Country
  1. 7.1 North America Carmustine Sales by Country
  2. 7.1.1 North America Carmustine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Carmustine Sales by Country (2021-2026)
  4. 7.1.3 North America Carmustine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Carmustine Market Size by Country
  6. 7.2.1 North America Carmustine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Carmustine Market Size by Country (2021-2026)
  8. 7.2.3 North America Carmustine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Carmustine Sales by Country
  2. 8.1.1 Europe Carmustine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Carmustine Sales by Country (2021-2026)
  4. 8.1.3 Europe Carmustine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Carmustine Market Size by Country
  6. 8.2.1 Europe Carmustine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Carmustine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Carmustine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Carmustine Sales by Country
  2. 9.1.1 Asia-Pacific Carmustine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Carmustine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Carmustine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Carmustine Market Size by Country
  6. 9.2.1 Asia-Pacific Carmustine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Carmustine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Carmustine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Carmustine Sales by Country
  2. 10.1.1 South America Carmustine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Carmustine Sales by Country (2021-2026)
  4. 10.1.3 South America Carmustine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Carmustine Market Size by Country
  6. 10.2.1 South America Carmustine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Carmustine Market Size by Country (2021-2026)
  8. 10.2.3 South America Carmustine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Carmustine Sales by Country
  2. 11.1.1 Middle East and Africa Carmustine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Carmustine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Carmustine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Carmustine Market Size by Country
  6. 11.2.1 Middle East and Africa Carmustine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Carmustine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Carmustine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Carmustine Value Chain Analysis
  2. 12.1.1 Carmustine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Carmustine Production Mode & Process
  7. 12.2 Carmustine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Carmustine Distributors
  10. 12.2.3 Carmustine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst